Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11.30M | $147.0M | 19.68% | -- | 2026-06-30 |
| FMR LLC | 6.79M | $88.0M | 11.82% | +6.78M | 2026-06-30 |
| UBS Group AG | 3.40M | $44.0M | 5.93% | +3.32M | 2026-06-30 |
| BRAIDWELL LP | 2.80M | $36.0M | 4.87% | +1.27M | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.51M | $32.0M | 4.36% | -- | 2026-06-30 |
| BlackRock, Inc. | 2.35M | $30.0M | 4.10% | +1.95M | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.13M | $27.0M | 3.70% | +210.3K | 2026-06-30 |
| Cormorant Asset Management, LP | 2.11M | $27.0M | 3.67% | -- | 2026-06-30 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1.94M | $25.0M | 3.38% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.70M | $22.0M | 2.96% | +520.0K | 2026-06-30 |
